Karuna Therapeutics Inc. (KRTX) Misses Q3 EPS by 44c
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Join SI Premium – FREE
Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q3 EPS of ($3.16), $0.44 worse than the analyst estimate of ($2.72).
For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Berenberg Starts Avio (AVIO:IM) at Hold
- Morgan Stanley Downgrades Smith & Nephew PLC. (SN:LN) (SNN) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
